Omalizumab facilitates rapid oral desensitization for peanut allergy

MacGinnitie, AJ; Rachid, R; Gragg, H; Little, SV; Lakin, P; Cianferoni, A; Heimall, J; Makhija, M; Robison, R; Chinthrajah, RS; Lee, J; Lebovidge, J; Dominguez, T; Rooney, C; Lewis, MO; Koss, J; Burke-Roberts, E; Chin, K; Logvinenko, T; Pongracic, JA

Schneider, LC (reprint author), Boston Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017; 139 (3): 873

Abstract

Background: Peanut oral immunotherapy is a promising approach to peanut allergy, but reactions are frequent, and some patients cannot be desensitized.......

Full Text Link